- Home
- NPT vs ANIK Comparison
NPT vs ANIK Comparison
Compare NPT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NPT | ANIK |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 134.8M |
| IPO Year | 2025 | 1993 |
Fundamental Metrics
Financial Performance| Metric | NPT | ANIK |
|---|---|---|
| Price | $5.90 | $10.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.9M | 154.1K |
| Earning Date | 02-27-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $797,148,640.00 | $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.51 | ★ 30.55 |
| 52 Week Low | $3.14 | $7.87 |
| 52 Week High | $13.48 | $18.35 |
Technical Indicators
Market Signals| Indicator | NPT | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 57.64 |
| Support Level | $5.90 | $9.97 |
| Resistance Level | $7.00 | $10.62 |
| Average True Range (ATR) | 1.56 | 0.38 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 10.64 | 59.79 |
Price Performance
Historical ComparisonAbout NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.